The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities
Open Access
- 25 July 2011
- journal article
- review article
- Published by Hindawi Limited in International Journal of Proteomics
- Vol. 2011, 1-17
- https://doi.org/10.1155/2011/373584
Abstract
Technological and scientific innovations over the last decade have greatly contributed to improved diagnostics, predictive models, and prognosis among cancers affecting women. In fact, an explosion of information in these areas has almost assured future generations that outcomes in cancer will continue to improve. Herein we discuss the current status of breast, cervical, and ovarian cancers as it relates to screening, disease diagnosis, and treatment options. Among the differences in these cancers, it is striking that breast cancer has multiple predictive tests based upon tumor biomarkers and sophisticated, individualized options for prescription therapeutics while ovarian cancer lacks these tools. In addition, cervical cancer leads the way in innovative, cancer-preventative vaccines and multiple screening options to prevent disease progression. For each of these malignancies, emerging proteomic technologies based upon mass spectrometry, stable isotope labeling with amino acids, high-throughput ELISA, tissue or protein microarray techniques, and click chemistry in the pursuit of activity-based profiling can pioneer the next generation of discovery. We will discuss six of the latest techniques to understand proteomics in cancer and highlight research utilizing these techniques with the goal of improvement in the management of women's cancers.Keywords
This publication has 132 references indexed in Scilit:
- Breast cancer in men in the United StatesCancer, 2010
- Combined use of biomarkers for detection of ovarian cancer in high-risk womenTumor Biology, 2010
- Screening for therapeutic targets of vorinostat by SILAC‐based proteomic analysis in human breast cancer cellsProteomics, 2010
- Molecular Analysis of Tumor Margins by MALDI Mass Spectrometry in Renal CarcinomaJournal of Proteome Research, 2010
- A Suite of Activity-Based Probes for Human Cytochrome P450 EnzymesJournal of the American Chemical Society, 2009
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massGynecologic Oncology, 2009
- Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19‐9 levels in pancreatic cancerProteomics, 2008
- The economic burden of noncervical human papillomavirus disease in the United StatesAmerican Journal of Obstetrics and Gynecology, 2008
- Direct Tissue Analysis by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry: Application to Kidney BiologySeminars in Nephrology, 2007
- Serine Hydrolase KIAA1363: Toxicological and Structural Features with Emphasis on Organophosphate InteractionsChemical Research in Toxicology, 2006